Managing Prescribing Rules, Implementing Real Time Verifications into Workflow During COVID-19
September 16th 2020The growth of telehealth, ongoing prescriber verification challenges, and the need for a universal patient identifier are all key issues that have arisen for pharmacists during the COVID-19 pandemic.
Read More
Supporting Pharmacy Students During and After the COVID-19 Pandemic
July 22nd 2020In the part 2 of a Pharmacy Times interview with Lucinda Maine, PhD, RPh, CEO of AACP and Lynette Bradley-Baker, PhD, CAE, senior vice president for strategic engagement at AACP, the 2 discussed how pharmacy schools are planning for the upcoming academic year and the future.
Watch
Students Face Challenges During Pandemic, But Experts Say ‘The Bar Has Not Been Lowered’
July 20th 2020Pharmacy Times spoke with Lucinda Maine, PhD, RPh, CEO of the American Association of Colleges of Pharmacy (AACP), and Lynette Bradley-Baker, PhD CAE, senior vice president for strategic engagement at AACP.
Watch
The Role of Professionalism in the Lives of Pharmacy Technician Students
July 16th 2020At the National Pharmacy Technician Association’s virtual Pharmacy Technician Student Summit, Jamie McGuire, the pharmacy technician program director, discussed the role of professionalism in the lives of pharmacy technician students.
Read More
Study: Menstrual Cups an Effective, More Comfortable Method of Diagnosis for Endometrial Cancer
June 23rd 2020A study presented at the Society of Gynecologic Oncology 2020 Annual Meeting on Women’s Cancer showed menstrual cups may provide a novel, less invasive, and more comfortable approach to the diagnosis of endometrial cancer.
Read More
Youth, Young Adults With Diabetes Today Have Worse Glycemic Control Than Prior Generations
June 17th 2020According to a recent study presented at the ADA’s 80th Scientific Sessions, youth and young adults with type 1 diabetes (T1D) in the United States today have worse glycemic control than prior generations.
Read More
The DPPOS is the long-term follow-up of the Diabetes Prevention Program (DPP), a multicenter trial conducted from 1996 to 2001 that established the success of either an intensive lifestyle program or treatment with metformin to prevent or delay the development of T2D in individuals who were considered at high risk for developing the disease.
Read More
Study: Oral Insulin Slows Metabolic Decline in Individuals at High Risk for Type 1 Diabetes
June 16th 2020Oral insulin (OI) slows insulin decline in those at high risk for type 1 diabetes (T1D), according to a poster session at the American Diabetes Association’s 80th virtual Scientific Sessions.
Read More